Montefiore Medical Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Montefiore Medical Center sits in the top decile of US sponsors by registered trial count (#102 of 15,742 sponsors by registered trial count).
Montefiore Medical Center: 345 sponsored US clinical trials, 64 recruiting.
Montefiore Medical Center sponsors 345 registered US clinical trials on ClinicalTrials.gov, 64 of them currently recruiting, and 207 completed. 88 of these trials are in Phase 3-4 (later-stage) and 71 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 4 trials.
Top-decile sponsor footprint
Montefiore Medical Center ranks in the top decile of sponsors by registered trial count (#102 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
207 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
345 total, page 7 of 7
Protocolized vs Nonprotocolized Treatment of Adult ED Patients With Acute Severe Pain
NCT00627367
Detemir: Role in Type 1 Diabetes
NCT00564395
Safety Study of Intravenous Hydromorphone Using Incremental 1mg Doses up to 2mg for Adult ED Patients
NCT00682435
The Efficacy of EMLA Cream vs. Synera Patch for Pain Reduction During Venipuncture in Children
NCT00530803
The Montefiore Metoclopramide Study
NCT00475306
Role of Exenatide in Type 1 Diabetes
NCT00456300
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
NCT00449787
Paracervical Block During Office Hysteroscopy
NCT00811187
Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
NCT00415584
Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
NCT00442767
Effect of Supine or Prone Position After Caesarean Birth
NCT01310153
A Study Evaluating the Association of Inflammation With Hemodialysis Access Type
NCT01011985
Prochlorperazine vs Metoclopramide
NCT00364806
A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor
NCT00432783
Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
NCT00305110
Sexual Function in Male Renal Transplant Patients
NCT00271830
Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines
NCT00122278
Trial Comparing Morphine to Hydromorphone in Elderly Patients With Severe Pain
NCT00305058
Use of a Probiotic Supplement to Prevent Asthma in Infants
NCT00113659
Divalproex Sodium ER in Adult Autism
NCT00211796
DNA Microarray Analysis of Gene Expression in Chronic Rhinosinusitis
NCT01001819
A Trial Comparing Different Dosing Regimens of Morphine in Patients With Moderate to Severe Pain
NCT00293969
Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
NCT00030706
Fluoxetine in Pediatric Body Dysmorphic Disorder
NCT00245635
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
NCT00231855
Safety and Efficacy Study of Hydromorphone and Morphine
NCT00195910
Engagement in HIV Primary Care Services
NCT00300170
The Use of ACE Inhibitors in the Early Renal Post-transplant Period
NCT00270153
Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
NCT00211744
Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen
NCT00200369
Prospective ED Headache Cohort Study
NCT00313703
Assessment of Early Genetic Changes in Smokers
NCT00200408
Evaluation of an HIV Outreach Program
NCT00300183
OSI-774 (Erlotinib, Tarceva) in Elderly Patients
NCT00200395
A Trial of Corticosteroids for Low Back Pain
NCT00290589
Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors
NCT00096317
Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus
NCT00231842
Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.
NCT00266708
Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism
NCT00211757
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
NCT00231868
Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00004864
Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00004863
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
NCT00003867
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
NCT00019474
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00002461
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 25 |
| Phase 2 | 46 |
| Phase 3 | 18 |
| Phase 4 | 70 |
Therapeutic Areas
What is open in the Montefiore Medical Center pipeline
64 recruiting of 345 indexed (19% open); 207 completed (60%).
Phase mix: 88 late (III/IV) vs 71 early (I/II) (balanced across stages).
Top condition: Low Back Pain (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Montefiore Medical Center: open-pipeline peers nationwide
Peers matched on 345 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Montefiore Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 345 trials (± recruiting share)
- National Institute of Mental Health (NIMH) · 343 trials · 12% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
- University of Arizona · 349 trials · 16% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
- University of Missouri-Columbia · 19% recruiting · 291 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Mclean Hospital · 19% recruiting · 140 trials
Related
What to do with this Montefiore Medical Center page
345 registered trials is a research-attention snapshot, not an endorsement of Montefiore Medical Center or any single study.
- 64 of Montefiore Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Low Back Pain is the condition Montefiore Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Montefiore Medical Center pipeline card: 345 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.